Review: Dabigatran does not differ from vitamin K antagonists for mortality or major bleeding

Included studies compared dabigatran, 150 mg twice daily, with VKAs alone or low-molecular weight heparin in adults ‰¥ 18 years of age, and had a treatment duration ‰¥ 90 days. Outcomes included mortality, major bleeding, and all bleeding.

0000605-201404150-02005

Publicado en Sin categoría |

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *